Replimune Group, Inc. (REPL)
19.89
+0.40
(+2.05%)
USD |
NASDAQ |
Nov 03, 11:42
Replimune Group Market Cap : 1.886B for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 1.848B |
| October 30, 2026 | 1.670B |
| October 29, 2026 | 1.649B |
| October 28, 2026 | 1.523B |
| October 27, 2026 | 1.237B |
| October 26, 2026 | 1.182B |
| October 23, 2026 | 1.086B |
| October 22, 2026 | 1.007B |
| October 21, 2026 | 984.24M |
| October 20, 2026 | 959.04M |
| October 19, 2026 | 927.97M |
| October 16, 2026 | 912.02M |
| October 15, 2026 | 986.76M |
| October 14, 2026 | 956.53M |
| October 13, 2026 | 1.017B |
| October 12, 2026 | 1.098B |
| October 09, 2026 | 1.127B |
| October 08, 2026 | 1.095B |
| October 07, 2026 | 1.109B |
| October 06, 2026 | 1.113B |
| October 05, 2026 | 1.104B |
| October 02, 2026 | 1.098B |
| October 01, 2026 | 1.130B |
| September 30, 2026 | 1.112B |
| September 29, 2026 | 1.092B |
| Date | Value |
|---|---|
| September 28, 2026 | 1.055B |
| September 25, 2026 | 1.038B |
| September 24, 2026 | 1.058B |
| September 23, 2026 | 1.088B |
| September 22, 2026 | 1.131B |
| September 21, 2026 | 1.081B |
| September 18, 2026 | 1.098B |
| September 17, 2026 | 1.081B |
| September 16, 2026 | 1.088B |
| September 15, 2026 | 1.094B |
| September 14, 2026 | 1.101B |
| September 11, 2026 | 1.085B |
| September 10, 2026 | 1.112B |
| September 09, 2026 | 1.214B |
| September 08, 2026 | 1.240B |
| September 04, 2026 | 1.263B |
| September 03, 2026 | 1.284B |
| September 02, 2026 | 1.342B |
| September 01, 2026 | 1.316B |
| August 31, 2026 | 1.285B |
| August 28, 2026 | 1.302B |
| August 27, 2026 | 1.310B |
| August 26, 2026 | 1.334B |
| August 25, 2026 | 1.327B |
| August 24, 2026 | 1.235B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kalaris Therapeutics, Inc. | 50.47M |
| Arrowhead Pharmaceuticals, Inc. | 8.477B |
| Oncolytics Biotech, Inc. | 49.24M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.965B |
Market Cap Related Metrics
| Price to Book Value | 9.208 |
| Price | 19.89 |
| Earnings Yield | -14.67% |